Table 1.
Characteristics of participants in each survey
| Qualitative study n (%) (n = 23) | Delphi first round n (%) (n = 35) | |
|---|---|---|
| Years of experience in cancer research | ||
| 5–9 | 7 (30) | 5 (14) |
| 10–14 | 2 (9) | 4 (12) |
| 15–19 | 5 (22) | 4 (12) |
| 20–24 | 2 (9) | 11 (31) |
| 25–29 | 5 (21) | 6 (17) |
| ≥30 | 2 (9) | 5 (14) |
| Sex | ||
| Male | 16 (70) | 24 (69) |
| Female | 7 (30) | 11 (31) |
| Institution of affiliation type | ||
| Comprehensive cancer centre | 11 (48) | 17 (49) |
| University hospital | 6 (26) | 11 (31) |
| Public research institute (not affiliated to a hospital or cancer centre) | 2 (9) | 4 (11) |
| National agency | 2 (9) | 0 |
| International or European agency | 2 (9) | 0 |
| Industry (pharmaceutical or consulting) | 0 | 3 (9) |
| Country | ||
| French institution | 18 (79) | 3 (9) |
| Italian institution | 1 (4) | 8 (23) |
| Dutch institution | 0 | 6 (17) |
| British institution | 0 | 4 (11) |
| Belgian institution | 0 | 3 (9) |
| Other European country institution | 3 (13) | 11 (31) |
| International institution | 1 (4) | 0 |
| Training | ||
| Masters degree (MSc) | 0 | 1 (3) |
| Medical degree (MD) | 2 (9) | 7 (20) |
| Medical degree and MSc | 1 (4) | 0 |
| Medical degree and PhD | 7 (30) | 14 (40) |
| Pharmacy degree (PharmaD) | 1 (4) | 0 |
| Pharmacy degree and PhD | 5 (22) | 1 (3) |
| PhD | 7 (30) | 12 (34) |
| PhD or MSc specialisation | 20 | 28 |
| Biology | 10 (50) | 13 (46) |
| Chemistry or biochemistry | 2 (10) | 2 (7) |
| Pharmacology | 2 (10) | 0 |
| Physics | 2 (10) | 2 (7) |
| Computer sciences | 1 (5) | 0 |
| Management of healthcare organisations | 0 | 2 (7) |
| Immunology | 1 (5) | 2 (7) |
| Genetics | 1 (5) | 3 (10) |
| Epidemiology/statistics | 0 | 2 (7) |
| Biotechnology | 1 (5) | 1 (4) |
| Pathology | 0 | 1 (4) |
Note: Two participants took part in both studies.